Evidence map›Paper›PMID 32216127›Full record

ArticleJournal of magnetic resonance imaging : JMRI2020

Radiomic Features of Primary Rectal Cancers on Baseline T

Jacob T Antunes, Asya Ofshteyn, Kaustav Bera, Erik Y Wang, Justin T Brady, Joseph E Willis, Kenneth A Friedman, Eric L Marderstein, Matthew F Kalady, Sharon L Stein and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 10 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 10 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. The Role of Radiomics in Fibrosis Crohn's Disease: A Review.Diagnostics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Jacob T AntunesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0002-5437-5639
Asya OfshteynDepartment of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Kaustav BeraDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Erik Y WangDepartment of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Justin T BradyDepartment of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Joseph E WillisDepartment of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Kenneth A FriedmanDepartment of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Eric L MardersteinLouis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Matthew F KaladyDepartment of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Sharon L SteinDepartment of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Andrei S PuryskoSection of Abdominal Imaging and Nuclear Radiology Department, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-6888-0417
Rajmohan PaspulatiDepartment of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Jayakrishna GollamudiDepartment of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Satish E ViswanathDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0003-4550-8337
University Hospitals of Cleveland · USCase Western Reserve University · USCleveland Clinic · USLouis Stokes Cleveland VA Medical Center · US

Funding

Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
Interdisciplinary Biomedical Imaging Training ProgramT32EB007509 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI DAVID Lynn WILSON, Xin Yu · 2007 to 2026
$5.6M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
RadxTools for assessing tumor treatment response on imagingU01CA248226 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TIWARI, PALLAVI, VISWANATH, SATISH EASWAR · 2020 to 2022
$1.4M
HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0M
A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear SlidesR43EB028736 · NIBIB · DIASCOPIC, LLC · PI MADABHUSHI, ANANT, SERIF, CARY · 2019 to 2019
$225k
Rad-path-omic tools for rectal cancer treatment evaluationF31CA216935 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ANTUNES, JACOB · 2019 to 2020
$71k
RadIO: A Novel Radiomics Toolkit to Predict and Characterize Response to Immunotherapy in Stage III Non-Small Cell Lung CancerI01BX004121 · VA · VETERANS HEALTH ADMINISTRATION · PI Anant Madabhushi, Charles J Nock · 2019 to 2026
–
BIOMEDICAL ENGINEERING RESEARCH FACILITIESC06RR012463 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI KUTINA, KENNETH L · 1997 to 1997
–
BLRD VA I01 BX004121BLRD VA IK6 BX006185Clinical and Translational Science Award Program at Case Western Reserve UniversityNCI NIH HHS 1F31CA216935-01A1NCI NIH HHS F31 CA216935NCI NIH HHS P50 CA150964NCI NIH HHS R01 CA202752NCI NIH HHS R01CA202752-01A1NCI NIH HHS R01 CA208236NCI NIH HHS R01CA208236-01A1NCI NIH HHS R01 CA216579NCI NIH HHS R01CA216579-01A1NCI NIH HHS U01 CA239055NCI NIH HHS U01CA239055-01NCI NIH HHS U01 CA248226NCI NIH HHS U24 CA199374NCI NIH HHS U24CA199374-01NCRR NIH HHS 1C06RR12463-01NCRR NIH HHS C06 RR012463NIBIB NIH HHS 1R43EB028736-01NIBIB NIH HHS R43 EB028736NIBIB NIH HHS T32 EB007509NIBIB NIH HHS T32EB00750912Ohio Third Frontier Technology Validation FundU.S. Department of Defense W81XWH-15-1-0558U.S. Department of Defense W81XWH-16-1-0329U.S. Department of Defense W81XWH-18-1-0440U.S. Department of Defense W81XWH-19-1-0668VA Merit Review Award IBX004121AWallace H. Coulter Foundation
6 · The paper itself

Abstract

backgroundTwenty-five percent of rectal adenocarcinoma patients achieve pathologic complete response (pCR) to neoadjuvant chemoradiation and could avoid proctectomy. However, pretreatment clinical or imaging markers are lacking in predicting response to chemoradiation. Radiomic texture features from MRI have recently been associated with therapeutic response in other cancers. PURPOSE: To construct a radiomics texture model based on pretreatment MRI for identifying patients who will achieve pCR to neoadjuvant chemoradiation in rectal cancer, including validation across multiple scanners and sites. STUDY TYPE: Retrospective. SUBJECTS: In all, 104 rectal cancer patients staged with MRI prior to long-course chemoradiation followed by proctectomy; curated from three institutions. FIELD STRENGTH/SEQUENCE: 1.5T-3.0T, axial higher resolution T ASSESSMENT: Pathologic response was graded on postsurgical specimens. In total, 764 radiomic features were extracted from single-slice sections of rectal tumors on processed pretreatment T STATISTICAL TESTS: Three feature selection schemes were compared for identifying radiomic texture descriptors associated with pCR via a discovery cohort (one site, N = 60, cross-validation). The top-selected radiomic texture features were used to train and validate a random forest classifier model for pretreatment identification of pCR (two external sites, N = 44). Model performance was evaluated via area under the curve (AUC), accuracy, sensitivity, and specificity.

resultsLaws kernel responses and gradient organization features were most associated with pCR (P ≤ 0.01); as well as being commonly identified across all feature selection schemes. The radiomics model yielded a discovery AUC of 0.699 ± 0.076 and a hold-out validation AUC of 0.712 with 70.5% accuracy (70.0% sensitivity, 70.6% specificity) in identifying pCR. Radiomic texture features were resilient to variations in magnetic field strength as well as being consistent between two different expert annotations. Univariate analysis revealed no significant associations of baseline clinicopathologic or MRI findings with pCR (P = 0.07-0.96). DATA

conclusionRadiomic texture features from pretreatment MRIs may enable early identification of potential pCR to neoadjuvant chemoradiation, as well as generalize across sites. LEVEL OF EVIDENCE: 3 TECHNICAL EFFICACY STAGE: 2.

Indexed as

Neoadjuvant TherapyRectal NeoplasmsChemoradiotherapyHumansMagnetic Resonance ImagingRetrospective Studiesmachine learningpathologic complete responseradiomicsrectal cancer

Identifiers

PMID32216127
PMCPMC7529659
OpenAlexW3013222846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.